Intravenous immunoglobulin (IVIG) is a type of medication used to treat people with immunodeficiencies, when the immune ...

Use of IV immunoglobulin was associated with a significantly reduced ICU length of stay in immunocompromised patients with respiratory viral infections.

In conclusion, we consider that the available data indicate that IVIg is not a lost cause for the therapy of MS 15,16, and that clinical trials are therefore warranted to determine if a ...

With an ever increasing number of patients being treated with IVIg for a wide array of immune-mediated disease, it is important that passive antibody transfer is considered when unexpected ...

The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved ...

With many patients, a critical element of treatment is infusion of intravenous immune globulin (IVIG). Congress should ensure that comparative effectiveness research does not allow for cost ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Piper Sandler重申了对argenx SE (NASDAQ: ARGX)股票的增持评级，目标价为$553.00。 该公司在与一位神经肌肉和神经免疫疾病领域专家讨论后，仍保持积极态度。讨论聚焦于当前用于治疗全身性重症肌无力(gMG)和慢性炎症性脱髓鞘性多发性神经病(CIDP)的生物制剂现状。 这位关键意见领袖(KOL)表示强烈偏好argenx的Vyvgart™用于gMG治疗，特别是作为二线 ...

To address this new diagnosis, my hematologist strongly urged me to get “intravenous immunoglobulin (IVIG) replacement ...

ADMA Biologics reported $107.2M in Q2 2024 revenue, a 78% YoY increase, with ASCENIV being the primary growth driver. See why ...

FcRn market with Vyvgart, poised for growth in autoimmune diseases and supports a bullish outlook. Read more on ARGX here.